Literature DB >> 22997461

Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

R Dummer1, A Hauschild, M Guggenheim, U Keilholz, G Pentheroudakis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22997461     DOI： 10.1093/annonc/mds229

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  41 in total

Review 1.  A review of sentinel lymph node biopsy for thin melanoma.

Authors:  K M Joyce; N M McInerney; C W Joyce; D M Jones; A J Hussey; P Donnellan; M J Kerin; J L Kelly; P J Regan
Journal:  Ir J Med Sci       Date:  2014-11-01       Impact factor: 1.568

Review 2.  Positron emission tomography in the follow-up of cutaneous malignant melanoma patients: a systematic review.

Authors:  Maria Danielsen; Liselotte Højgaard; Andreas Kjær; Barbara Mb Fischer
Journal:  Am J Nucl Med Mol Imaging       Date:  2013-12-15

3.  Matrix metalloproteinase-12 expression is increased in cutaneous melanoma and associated with tumor aggressiveness.

Authors:  Zixi Zhang; Shaojun Zhu; Yang Yang; Xianjie Ma; Shuzhong Guo
Journal:  Tumour Biol       Date:  2015-06-04

4.  EANM practice guidelines for lymphoscintigraphy and sentinel lymph node biopsy in melanoma.

Authors:  Christina Bluemel; Ken Herrmann; Francesco Giammarile; Omgo E Nieweg; Julien Dubreuil; Alessandro Testori; Riccardo A Audisio; Odysseas Zoras; Michael Lassmann; Annette H Chakera; Roger Uren; Sotirios Chondrogiannis; Patrick M Colletti; Domenico Rubello
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-07-25       Impact factor: 9.236

5.  High-risk cutaneous melanoma follow-up: time for more intensive surveillance?

Authors:  Michael Davidson; Paul Lorigan; James Larkin
Journal:  Melanoma Manag       Date:  2014-09-05

Review 6.  Radiocolloid-based dynamic sentinel lymph node biopsy in penile cancer with clinically negative inguinal lymph node: an updated systematic review and meta-analysis.

Authors:  Zi-Jun Zou; Zhi-Hong Liu; Liang-You Tang; Yu-Jie Wang; Jia-Yu Liang; Ruo-Cheng Zhang; Yong-Quan Tang; Yi-Ping Lu
Journal:  Int Urol Nephrol       Date:  2016-08-30       Impact factor: 2.370

7.  Improvement of overall survival in stage IV melanoma patients during 2011-2014: analysis of real-world data in 441 patients of the German Central Malignant Melanoma Registry (CMMR).

Authors:  Andrea Forschner; Felizitas Eichner; Teresa Amaral; Ulrike Keim; Claus Garbe; Thomas Kurt Eigentler
Journal:  J Cancer Res Clin Oncol       Date:  2016-11-22       Impact factor: 4.553

8.  Limited role for histopathological examination of re-excision specimens of completely excised melanomas.

Authors:  A C de Waal; R Vossen; K K H Aben; L A L M Kiemeney; M M van Rossum; W A M Blokx
Journal:  Virchows Arch       Date:  2014-05-29       Impact factor: 4.064

9.  Metastatic melanoma: pretreatment contrast-enhanced CT texture parameters as predictive biomarkers of survival in patients treated with pembrolizumab.

Authors:  Carole Durot; Sébastien Mulé; Philippe Soyer; Aude Marchal; Florent Grange; Christine Hoeffel
Journal:  Eur Radiol       Date:  2019-01-15       Impact factor: 5.315

Review 10.  Guidelines of the Brazilian Dermatology Society for diagnosis, treatment and follow up of primary cutaneous melanoma--Part I.

Authors:  Luiz Guilherme Martins Castro; Maria Cristina Messina; Walter Loureiro; Ricardo Silvestre Macarenco; João Pedreira Duprat Neto; Thais Helena Bello Di Giacomo; Flávia Vasques Bittencourt; Renato Marchiori Bakos; Sérgio Schrader Serpa; Hamilton Ometto Stolf; Gabriel Gontijo
Journal:  An Bras Dermatol       Date:  2015 Nov-Dec       Impact factor: 1.896
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.